Cargando…
Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04
BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activ...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557422/ https://www.ncbi.nlm.nih.gov/pubmed/28806986 http://dx.doi.org/10.1186/s12906-017-1892-z |
_version_ | 1783257199994208256 |
---|---|
author | Zhang, Chen Li, Juan Wang, Jing Song, Xingling Zhang, Jianjun Wu, Shang Hu, Chunlong Gong, Zhiyuan Jia, Le |
author_facet | Zhang, Chen Li, Juan Wang, Jing Song, Xingling Zhang, Jianjun Wu, Shang Hu, Chunlong Gong, Zhiyuan Jia, Le |
author_sort | Zhang, Chen |
collection | PubMed |
description | BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activities, including reducing blood lipids. In the present study, three novel polysaccharide types, including exopolysaccharides (EPS), enzymatic EPS (EEPS) and acidic EPS (AEPS) were isolated, and the hypolipidaemic and hepatoprotective effects were investigated to better understand possible hypolipidaemic mechanisms and their hepatoprotective effects. METHODS: The EPS was hydrolysed by snailase (dissolved in 1% acetic acid, pH = 6) and H(2)SO(4) (1 M) to obtain EEPS and AEPS, respectively. The in vitro antioxidant activities were measured by investigating the reducing power and the scavenging effects on radicals of hydroxyl, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide anion. The hyperlipidaemic mice were induced by perfusing a high-fat emulsion. In addition to the hepatic histopathology, the following biochemical analyses were performed to investigate the antioxidative effects, including the activities of alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT). Triacylglycerol (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and lipid peroxidation (LPO) levels were also measured in serum and liver homogenate. RESULTS: Supplementation of EPS, EEPS and AEPS could significantly improve blood lipid levels (TC, TG, HDL-C, and LDL-C), hepatic lipid levels (TC and TG), hepatic enzyme activities (ALP, ALT, and AST) and antioxidant status (GSH-Px, SOD, T-AOC, MDA, and LPO). In addition, histopathological observations indicated that these polysaccharides had potential effects in attenuating hepatocyte damage. CONCLUSION: These results demonstrated that both EPS and its hydrolysates EEPS and AEPS might effectively reduce serum lipid levels and protect against high-fat diet-induced hyperlipidaemia, indicating that they could be used as functional foods and natural hepatoprotectants. |
format | Online Article Text |
id | pubmed-5557422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55574222017-08-16 Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 Zhang, Chen Li, Juan Wang, Jing Song, Xingling Zhang, Jianjun Wu, Shang Hu, Chunlong Gong, Zhiyuan Jia, Le BMC Complement Altern Med Research Article BACKGROUND: Hyperlipidaemia is the major risk factor contributing to the development and progression of atherosclerosis, fatty liver and cerebrovascular disease. Pleurotus eryngii (P. eryngii) is rich in biologically active components, especially polysaccharides that exhibit various biological activities, including reducing blood lipids. In the present study, three novel polysaccharide types, including exopolysaccharides (EPS), enzymatic EPS (EEPS) and acidic EPS (AEPS) were isolated, and the hypolipidaemic and hepatoprotective effects were investigated to better understand possible hypolipidaemic mechanisms and their hepatoprotective effects. METHODS: The EPS was hydrolysed by snailase (dissolved in 1% acetic acid, pH = 6) and H(2)SO(4) (1 M) to obtain EEPS and AEPS, respectively. The in vitro antioxidant activities were measured by investigating the reducing power and the scavenging effects on radicals of hydroxyl, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and superoxide anion. The hyperlipidaemic mice were induced by perfusing a high-fat emulsion. In addition to the hepatic histopathology, the following biochemical analyses were performed to investigate the antioxidative effects, including the activities of alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT). Triacylglycerol (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and lipid peroxidation (LPO) levels were also measured in serum and liver homogenate. RESULTS: Supplementation of EPS, EEPS and AEPS could significantly improve blood lipid levels (TC, TG, HDL-C, and LDL-C), hepatic lipid levels (TC and TG), hepatic enzyme activities (ALP, ALT, and AST) and antioxidant status (GSH-Px, SOD, T-AOC, MDA, and LPO). In addition, histopathological observations indicated that these polysaccharides had potential effects in attenuating hepatocyte damage. CONCLUSION: These results demonstrated that both EPS and its hydrolysates EEPS and AEPS might effectively reduce serum lipid levels and protect against high-fat diet-induced hyperlipidaemia, indicating that they could be used as functional foods and natural hepatoprotectants. BioMed Central 2017-08-14 /pmc/articles/PMC5557422/ /pubmed/28806986 http://dx.doi.org/10.1186/s12906-017-1892-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhang, Chen Li, Juan Wang, Jing Song, Xingling Zhang, Jianjun Wu, Shang Hu, Chunlong Gong, Zhiyuan Jia, Le Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title | Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title_full | Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title_fullStr | Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title_full_unstemmed | Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title_short | Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04 |
title_sort | antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from pleurotus eryngii si-04 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557422/ https://www.ncbi.nlm.nih.gov/pubmed/28806986 http://dx.doi.org/10.1186/s12906-017-1892-z |
work_keys_str_mv | AT zhangchen antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT lijuan antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT wangjing antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT songxingling antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT zhangjianjun antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT wushang antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT huchunlong antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT gongzhiyuan antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 AT jiale antihyperlipidaemicandhepatoprotectiveactivitiesofacidicandenzymatichydrolysisexopolysaccharidesfrompleurotuseryngiisi04 |